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Transplantation of the Livl!r 
Thomas E. Starzl, M.D., Ph.D., 
Charles W. Putnam, M. D., 
and Jacques L. Corman, M.D., F.R.C.S.(C) 
The ultimate therapeutic step in the treat-
ment of any terminal hepatic disease is the 
provision of a new liver with or without re-
moval of the afflicted native organ. The first 
clinical trial of liver transplantation took 
place in 1963.24 In the subsequent decade, 
more than 150 attempts have been made 
throughout the world, 74 of these at our own 
institution. The historical aspects of both ani-
mal and human liver transplantation have 
been summarized in a book in which the 
world literature was brcught up to date as of 
the spring of 1969.19 
KINDS OF OPERATIONS 
AUXILIARY TRANSPLANTATION 
Liver transplantation was first performed 
and recorded by Welch in 1955.s1 Welch en-
visioned treating patients who were dying of 
cirrhosis or other non-neoplastic diseases for 
whom the removal of the diseased native liver 
would n?; be obligatory. With the Welch 
operation, the extra canine liver was placed 
in the right paravertebral gutter or the right 
side of the pelvis. Its hepatic arterial supply 
was derived from the aorta or from the iliac 
artery. Venous inflow was reconstituted by 
anastomosing the distal inferior vena cava or 
a distal iliac vein to the homograft portal 
vein. Outflow was into the inferior vena cava 
(Fig. 35-1A). 
The use of auxiliary homografts for the 
treatment of benign hepatic disease initially 
had a special attractiveness, and still does in 
the 'minas of .a minority of students of liver 
transplantation. The adherents of auxiliary 
transplantation argue -that sacrifice of the re-
maining function of the failing recipient liver 
could be avoided, providing some reserve in 
the event of poor initial performance by the 
homograft, due to ischemia or to a severe but 
reversible rejection. This might be a particu-
larly significant advantage in patients with 
biliary atresia~ since the synthesizing func-
tions of the liver are often retained until the 
terminal stages of this disease. Second, it was 
initially assumed that the placement of an 
extra liver would be safer and technically less 
demanding than the orthotopic procedure, an 
assumption that has not been validated by 
actual experience. 
With auxiliary transplantation, the results 
in animals have been inferior to those with 
liver replacement, partly because co-existing 
livers have the capacity to damage each other 
to a variable degree according to which organ 
is the "dominant" one. Factors favoring dom-
inance include a splanchnic source of the 
blood for portal venous inflow, perfect biliary 
drainage, optimal total hepatic blood flow, 
and unimpeded venous outflow. An auxiliary 
canine liver graft, which does not enjoy these 
advantages relative to the host liver, under-
goes rapid atrophy 12 by mechanisms that 
have evoked numerous and heated discus-
sions.19 More recently, evidence has been ac-
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A. 
B. 
FIG. 35-1. Marchioro's first experiment ~ithauxiliary hepatic homotransplantation, which 
suggested competition between coexisting livers. A) Mpdification of Welch-Goodrich tech-
nique. The portal blood flow to the transplant was from the systemic venous system. The 
homograft underwent rapid atrophy. B) The portal venous inflow was obtained from the 
nonhepatic splanchnic bed. The host liver received only an arterial supply. With these 
changes, the homograft atrophy was prevented and in some experiments, the shrinkage now 
involved host livers. (Marchioro, T. L.. et al.: Surg. Gynerol. Obstet., 121:17,1965.) 
quired to explain the beneficial effect of per-
fusing the portal vein with splanchnic venous 
blood. It has been shown that the "hepato-
trophic factors" in this kind of venous blood 
emanateirom the pancreas and that the most 
important constituent is apparently endog-
enous insulin.21 Since insulin is largely re-
moved by a single passage through the liver, 
the first organ having access to pancreatic 
blood would deprive the second liver of an 
adequate supply of this hormone. 
U ntiI 1973, clinical auxiliary liver trans-
plantation had never resulted in the signifi-
cant prolongation of recipient life. The results 
had been so poor that the number of attempts 
at the auxiliary operation declined virtually to 
zero. A contributory factor was that the place-
ment of an extra organ had often proved to be 
more difficult, rather than technically simpler, 
than in liver replacement. 
But early in 1973, Fortner lightened the 
pessimism about auxiliary transplantation by 
revascularizing a homograft using the prin-
ciples described by Marchioro et al.12 shown 
in Figure 35-1B, whereby the splanchnic 
blood is directed through the heterotopically 
located liver. The human version of this pro-
cedure is shown in Figure 35-2. Fortner's pa-
tient suffered from biliary atresia. After· oper-
ation, the bilirubin fell to normal, the native 
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Indications for Hepatic Transplantation 1149 
liver underwent marked shrinkage, and the 
splenomegaly and hypersplenism were re-
lieved. The follow-up in the case is now more 
than six months.7 In view of this encouraging 
experience, additional clinical trials of auxil-
iary transplantation will probably be forth-
coming. 
ORTHOTOPIC TRANSPLANTATION 
The alternative approach to hepatic trans-
plantation is liver replacement (or orthotopic 
transplantation). With this operation, the dis-
eased host liver is removed, creating a space 
into which the graft is transplanted with as 
normal an anatomic reconstruction as pos-
sible. Survival in dogs and humans has been 
achieved exceeding 9% and 4% years, re-
spectively. The remarks in succeeding sec-
tions will pertain to the more promising ortho-
topic transplantation as opposed to the auxil-
iary operation discussed above. 
INDICATIONS FOR HEPATIC 
TRANSPLANTATION 
No matter what the underlying disease, 
certain criteria should be met before accepting 
patients for chronic immunosuppression and 
transplantation. None of the contraindications 
is absolute, although they may be very strong. 
For example, pre-existing systemic or local 
infections would create highly unfavorable 
conditions. So would diseases of organs other 
than the liver, for example, co-existing severe 
heart disease, or a history of sociopathic be-
havior which would prevent postoperative 
management. From our experience with renal 
transplantation, we have learned that people 
who are more than 45 or 50 years of age fre-
quently cannot withstand the rigors of inten-
sive immunosuppression. They may develop 
muscle wasting and other physical incapaci-
ties, have steroid-induced pancreatitis more 
frequently than younger patients, and have a 
ReciPient 
FIG. 35-2. A technique of 
auxiliary liver transplantation 
in which the homograft receives 
through its portal vein venous 
blood derived from the splanch-
nic bed. (Starzi, T. E. and Put-
nam, C. W.ID) 
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higher incidence of a variety of gastrointes-
tinal complications, including gastroduodenal 
hemorrhage and colonic problems.u 
BENIGN DISEASE 
Appreciation of this fact has probably been 
responsible for the rather small number of 
liver transplantations for the indication of al-
coholic cirrhosis. 
The outcome is somewhat more predictable 
in patients with post-necrotic cirrhosis and 
Any patient with terminal liver disease of less common disorders such as primary biliary 
non-neoplastic origin is a potential candidate cirrhosis, medically refractory Wilson's hep-
for liver transplantation. Of the various possi- atolenticular degeneration, irreparable biliary 
bilities, extrahepatic biliary atresia is perhaps duct injury, and some of the more lethal in-
the least questionable, since death is inevi- born errors of metabolism. But even with 
table after a relatively predietable interval these diseases, there was initial reluctance to 
and without any hope in the remaining life proceed until incontrovertible evidence was 
for rehabilitation. Because of these considera- obtained that extended survival was possible 
tions, children can be considered for this in humans after liver transplantation. Now 
operation while they are still in relatively that the feasibility of long-term survival has 
good health. With intrahepatic biliary atresia, been proven, it will be possible to relax the 
more conservatism is exercised since some of restrictions 'on intervention so that treatment 
these children can survive for many years. may be instituted before the terminal st&ges 
The problem of the proper time for liver of the disease. Otherwise, it is unlikely that 
transplantation may be difficult for almost all the results in future cases will be significantly 
other kinds of non-neoplastic liver disease. improved. 
This is particularly true if alcoholism is a At present, it is our belief that all patients ' 
significant etiologic facto fIthat could be elim- who are dying from an otherwise untreatable 
inated by abstinence. An gastroenterologists non-neoplastic hepatic disease should be con-
of experience have seen occasional patients sidered- as possible candidates for liver trans-
with Laennec's ..cirrhosis who were apparently plantation providing there ar-e no other rea-
dying of profound hepatic failure but who sons, such as those discussed at the beginning 
recovered and subsequently left the ll£spitfl._ of this section, against the decision. 
FIG . 35-3. Destruction of the homograft by tumor recurrence in a 15-year-old recipient, 
whose indication for liver transplantation was hepatoma. The posteroanterior and lateral 
liver scans were obtained with 99mtechnetium. A) 68 days : Nonnal scan. B) 94 days: The 
. patient had become jaundiced. Hepatomegaly is evident. C) 101 days: Multiple areas of 
poor isotope concentration are now visible . D) 111 days: The process has continued its 
rapid progression. By the time of death one month later, the homograft was almost com-
pletely replaced with carcinoma (see Fig. 35--4). (Starzl, T. E . and Putnam , C. W.'9) 
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Indications for Hepatic Transplantation 1151 
FIG. 35-4. The liver homograft at autopsy, 143 days post-transplantation, of the patient 
whose scans are depicted in Figure 35-3. The graft has been replaced by tumor except for a 
very small residual area of hepatic parenchyma (arrow) . (Starzl , T. E. and Putnam, C. W.1D ) 
THE QUESTlON OF HEPATIC MALIGNANCY 
Orthotopic liver transplantation was first 
attempted in humans for the indication of 
primary liver malignancy. The major reason 
for this policy was that complete removal of 
the recipient liver was an obligatory compo-
nent of the undertaking if cure was to be 
achieved. Thus, liver replacement was con-
ceived as a means for extending the limits of 
resectability in patients who did not have 
extrahepatic spread of their tumors. 
Actual experience with liver replacement 
for the indication of primary hepatic malig-
nancy has led us to declare a moratorium on 
such cases. At the University of Colorado, a 
total of 13 patients have undergone liver re-
placement because of the preoperative diag-
nosis of primary hepatic malignancy. In six 
cases, the attempt was "successful" in a tech-
nical sense, with survival for 'at least 2Y2 post-
operative months. All six recipients developed 
recurrence of malignancy from two to thirteen 
months later. Eventually, the six patients died 
and in most instances, the tumor recurrence 
either caused death or contributed to it in an 
important way. Lethal and widespread me-
tastases were responsible for death as early as 
143 days after operation and as late as 14 
months (Figs. 35-3, 35-4). 
Hepatoma was the histopathologic diagnosis 
in all but one of the foregoing six cases 
wi th postoperati ve follow-ups exceeding 2 Y2 
months. The exceptional patient had a heman-
gioendotheliosarcoma. Although he made a 
1152 Transplantation of the Liver 
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tion recurrence and spread. Three patients 
with intrahepatic ductal cell carcinomas have 
now received transplants at our center for 
this lesion. Two survived the early postopera-
tive period; neither has evidence of recur-
rence. 
It is too early to conclude once and for all 
that liver replacement in the face of hepatic 
malignancy is an unacceptable undertaking. 
One of our patients, whose primary reason for 
liver transplantation was biliary atresia, had 
an incidental hepatoma in the total hepatec-
tomy specimen. Her preoperative serum con-
II... 
\ 
\ \ 8 
\ ~ 
\s , 
~ tained almost 4 mg. per cent of alpha feto-
~ protein. After operation in 1970, the alpha 
~ fetoprotein disappeared from the serum (Fig. 
li---~--~--~--~~ .. ~~~ 
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TIME IN MONTHS 
FIG. 35-5. Alpha-fetoprotein determinations in 
a 3-year-old child who underwent transplanta-
tion for biliary atresia. A small hepatoma was 
discovered within the operative specimen. The 
child is now 3* years after transplantation. Alpha-
fetoprotein determinations continue to be nega-
tive and she remains free,jf tumor. (StaTZI, 
T. E. and Putnam, C. W. in Abdominal Operations 
(Maingot, R., Ed.). 6th Edition. New York, Ap-
pleton-Century-Crofts, 1974, pp. 1247-1271.) 
satisfactory recovery from operation, he_also. 
developed widespread metastases and died in 
less than four months. 
We have suggested that the immunosuppres-
sive therapy necessary to prevent rejection 
may itself have contributed to the aggressive-
ness of the metastatic growth. Such specula-
tions are based in some way on the surveillance 
hypothesis of cancer proposed by Thomas 29 
and Burnet 3 which holds that the immune 
system is an important factor in the limitation 
of growth of mutant neoplastic cells. Whether 
immunosuppression and the consequent loss 
of this restraining influence upon tumor 
growth contributed to the unsuccessful out-
come under the specific conditions of liver 
transplantation cannot be proved, since the 
results may only have been a reflection of the 
highly malignant natural history of these 
neoplasms. 
It is conceivable that other kinds of hepatic 
malignancies with a more indolent natural 
course may be less prone to post-transplanta-
35-5) and has not recurred in the 3% years 
of post-transplantation life. Apparently, this 
child has achieved a cure from her hepatoma. 
Isolated "cures" of hepatic malignancy after 
liver replacement have also been reported by 
CaIne f and by Daloze.5 Nevertheless, the high 
rate of recurrence of tumor in our hands has 
made us reluctant, for the time being, to ac-
cumulate more such cases. . 
DONOR PROCUREMENT 
In most transplantation centers in the 
United States, the criteria of brain death based 
-Upon the concept of irreversible brain injury 
have been accepted for the pronouncement of 
death. Under these conditions and with an 
ideal cadaveric donor, the interval of nor-
mothermic ischemic injury is reduced essen-
tially to zero, inasmuch as the dissection prior 
to the removal of the liver or other organs can 
be carried out or even completed in the pres-
ence of an effective circulation. It is of more 
than passing interest that public acceptance 
of these conditions of organ removal has been 
widespread in America with almost no nega-
tive outcries. 
However, in at least half of the potential 
cadaveric donors seen by us, there is a need 
for far greater urgency than under the ideal 
conditions just discussed. One common cir-
cumstance seen by us is the development of 
an irreversible cardiac arrest in someone al-
ready considered to have a hopeless brain in-
jury. When this occurs, the organs can be 
saved for transplantation by the rapid inser-
tion of cannulas through a femoral artery and 
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vein into the great abdominal vessels. The 
cadaver may then be connected to a cardio-
pulmonary bypass. With a heat exchanger in-
terposed in the circuit, the body may be simul-
taneously perfused and cooled (Fig. 35-6). 
Finally, refinements in technology have made 
possible the successful preservation of canine 
and human livers for many hours after their 
excision and insertion into perfusion cham-
bers.2 With these various advances, all 
achieved within the last decade, it is no longer 
excusable to carry out a liver transplantation 
with an organ that has been significantly in-
jured either pre- or post-mortem. 
DONOR-RECIPIENT MATCHING 
With the exception of biliary atresia, most 
potential recipients of liver homografts have 
a very brief period of candidacy for trans-
plantation. If an organ cannot be quickly 
found, death supervenes. Obviously, highly 
discriminating donor selectivity is not prac-
tical under these circumstances and for thal' 
matter any selectivity, however supportable 
on immunologic criteria, may cost the patient 
his only chance for treatment. Ii is in the con-
text of such urgency that donor-recipient 
matching will be considered below. 
FIC. 35-6. Technique of ex-
tracorporeal perfusion with a 
heart-lung machine. In the 
event of an irreversible cardiac 
arrest in a patient with a hope-
less brain injury, catheters are 
rapidly inserted via the fem-
oral vessels into the aorta 
and vena cava. The extracor-
po real circuit is primed with a 
glucose or electrolyte solution 
to which procaine and heparin 
are added. The cadaver is thus 
anticoagulated with the first 
surge of the pump. Tempera-
ture control is provided by the 
heat exchanger. Cross-clamp-
ing the thoracic aorta limits 
perfusion to the lower part of 
the body. (Starzl, T. E. and 
Putnam, C. W.1!)) 
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THE HL-A SYSTEM 
Several years ago, it was hoped that clini-
cal results after cadaveric transplantation 
might be improved by effective donor-re-
cipient matching of histocompatibility 
(HL-A) antigens. Unfortunately, the results 
obtained so far with hepatic, cardiac, and 
renal transplantation have not correlated well 
with the quality of the matches. These find-
ings in our own experience and in that of 
others have led us, for the momentj.to ignore 
the question of HL-A matching for liver trans-
plantation. Nor do we even use most favorable 
matching as an instrument of selection among 
a given group of candidates for transplanta-
tion. At the present time, our major criterion 
concerns who has the most pressing need, 
THE .QUESTION OF PREFORMED ANTIBODIES 
ABO Matching. When a seriously ill per-
son is identified as a possible organ donor, the 
ABO-blood type is determined. In considering 
potential recipients for the liver, it is desirable 
that they have the same ABO group as the 
donor, Failing this, the rules of tissue trans-
fer summarized in Table 35-1 are followed. 
The guidelines ar~esigned to avoid the trans-
" 
~K 
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TABLE 35-1. DIRECTION OF ACCEPTABLE 
MISMATCHED TISSUE TRANSFER * 
o to non-O 
Rh- to Rh+ 
Rh+ to Rh-
A to non-A 
B to non-B 
AB to non-AB 
Safe 
Safe 
Relatively Safe 
Dangerous 
Dangerous 
Dangerous 
* 0 is universal donor. AB is universal recipient. 
plantation of an organ into a recipient who 
possesses preformed antidonor isoagglutinins. 
Red blood cell antigens against which these 
isoagglutinins react are found not only in red 
cells but also in most nucleated cells. Thus, 
violation of the rules of tissue transfer (Table 
35-1) can result in an acute immunologic in-
sult to a graft. With kidney h1mografts, imme-
diate rejection has commonly occurred.1s 
Since red cell antigens are also found in 
hepatocytes, the principles. enunciated in Table 
35-1 have been scrupulQt.lsly followed at our 
center in all cases of live~ transplantation un-
til recently. Then, three ABO mismatched 
livers were used (Table 35-2). Hyperacute 
rejection did not occur and no obvious adverse 
consequences were seen. The titers of an-tigraft 
isoagglutinins were highly variable -and, at-
least in one case, reached prodigious levels 
(Table 35-3). This ability of the liver to re-
main healthy under conditions whi(h would 
be predictably harmful to most kidneys is a 
noteworthy feature which has been seen in 
other preformed antibody situations to be dis-
cussed later. 
Cytotoxins. For example, in renal trans-
plantation, the presence of antigraft cytotoxic 
antibodies in the recipient carries an over-
whelming risk of hyperacute rejection, even 
higher than with transplantation across the 
ABO barrier. The events of hyperacute rejec-
tion include clearance by the graft of the anti-
bodies, formed blood elements, and clotting 
factors.10, 20, 23 The result is that the small 
vessels of the organ become occluded with 
diffuse thrombi and the graft undergoes in-
farction. When xenografting is performed be-
tween widely divergent species, as from the 
pig to the dog, organs are hyperacutely re-
jected by the same mechanism. However, the 
liver is destroyed more slowly than the kid-
neyy,16 Thus we have concluded that even 
in this devastatingly severe experimental 
model, the liver is relatively resistant to'by-
peracute rejection. 
The resistance to hyperacute rejection prob-
ably is a general principle in clinical practice 
as well. During the last year, three patients 
have been given livers from donors against 
which cytotoxic antibodies' were found. In all 
three cases, cytotoxins were also present 
against most of the donors of an indifferent 
lymphocyte screening panel. Thus, the pros-
pects of finding a liver without a positive cy-
totoxic antibody crossmatch were considered 
nil. As a consequence, a decision was made to 
proceed despite the potentially adverse prog-
nostic implications. 
None of the three patients developed hy-
peracute rejection, although two of them 
eventually died (Table 35-4). In Case 3, the 
TABLE 35-2. THREE CASES OF TRANSPLANTATION OF ABO INCOMPATIBLE LIVERS 
'-- DONOR RECIPIENT CASE 
NUMBER ABO Types 
AB ~ A 
2 AB ~ A 
3 A o 
PRE-OP 
ISOAGGLUTININ 
TITER 
1:4 (anti-B) 
1 :32 (anti-B) 
1 :512 (anti-A) 
SURVIVAL 
173 days 
61 days 
41 days 
CAUSE OF DEATH 
Sepsis 
Sepsis 
Pulmonary emboli 
Liver failure 
Disseminated herpes 
and cytomegalovirus 
Pulmonary emboli 
Brain infarction 
• 
, 
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TABLE 35-3. ANTIGRAFT ISOAGGLUTININ TITERS IN THE THREE 
RECIPIENTS OF ABO INCOMPATIBLE LIVERS DESCRIBED 
IN TABLE 2 
POST-OP 
DAY 
o 
1 
3 
5 
7 
9 
11 
13 
15 
17 
19 
21 
28 
35 
42 
49 
56 
63 
70 
77 
84 
CASE 1 
(Anti-B) 
1 :4 
1 :4 
1: 1 
1:1 
1: 1 
1 :4 
1 :4 
1 :4 
1 :4 
1:2 
1: 1 
1: 1 
1:2 
1:2 
1:2 
1:2 
1:2 
1:2 
1 :8 
1:4 
homograft seemed to have been severely dam-
aged by ischemia, although its poor initial 
function could huve been a manifestation of 
acute antibody-mediated injury. After 10 days, 
the organ was removed and replaced by a 
chimpanzee heterograft, against which the 
recipient cytotoxins also reacted. The chim-
panzee liver functioned for most of the 14 
CASE 2 
(Anti-B) 
1 :32 
1:16 
1 :4 
1:2 
1 :8 
1 :64 
1:64 
1 :32 
1: 16 
1 :8 
1 :4 
1:4 .• 
1:2 
1 :2 
1 :2 
1: r-
1 :8 
CASE 3 
(Anti-A) 
1:512 
1 :64 
1 :64 
1 :2048 
1:8192 
1:8192 
1:4096 
1:2048 
1:1024 
1:1024 
1:512 
1 :256 
1: 128 
subsequent days of the patient's life. Upon 
pathologic examination, the initial homograft 
had many focal areas of necrosis compatible 
with the diagnosis of ischemic injury. In con-
trast, the heterograft was well preserved. Cen-
trilobular cholestasis was a prominent feature. 
Otherwise, there was little evidence of rejec-
tion. 
TABLE 35-4. THREE CASES OF HEPATIC. TRANSPLANTATION IN WHICH THE 
RECIPIENTS HAD ANTIDONOR CYTOTOXIC ANTIBODIES 
PRE-OP 
CASE CYTOTOXICITY 
NUMBER TITER SURVIVAL CAUSE OF DEATH 
1 1:2 Alive 
2 1:64 26 days Extra-hepatic 
biliary obstruction 
Peritonitis 
Bleeding diathesis 
3 (Homograft) 1: 16 (Removal of the 
graft at 10 
days) 
(Heterograft) 1: 16 14 days after re- Pulmonary edema 
transplantation Hemorrhage 
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It goes without saying that preformed anti-
body states should be avoided if at all possible. 
However, the experience cited both with the 
ABO red cell and cytotoxic antibodies makes 
it clear that this kind of positive cross-match 
is not an absolute contraindication to liver 
transplantation. 
PREOPERATIVE PREPARATION 
Prospective liver recipients are generally 
poor risks for a major operation. Those with he-
patic failure from non-neoplastic disease may 
even appear at first evaluation to be hopeless. 
Paracentesis or thoracentesis may be required 
before anesthesia can be contemplated. Trans-
fusions of blood or albumin may be useful for 
the correction of blood volume or other fluid 
space abnormalities. If fresh whole blood, 
fresh frozen plasma or platelets are judiciously 
given, some improvement in coagulation may 
be possible. Otherwise, there is usually little 
of real value that can be done to reduce the 
impending operative hazatsls. 
Theoretically, one way of transiently in-
creasing liver function before the definitive 
procedure would~be with ex vivo hepatic sup-
port, using an extracorporeal heterologous 
liver by techniques adapted from Eiseman 
ward in better condition than at the time of 
their departure. 
Secondary abnormalities of organs other 
than the liver can sometimes be effectively 
ameliorated. For example, the effects of renal 
failure secondary to the hepatorenal syndrome 
can be treated with the artificial kidney. Pul-
monary manifestations may be improved by 
simple tracheobronchial toilet, particularly if 
aspiration has occurred. 
The inability to be more specific in pre-
paring patients for surgery means that most 
prospective recipients cannot be maintained 
for very long during a search for a suitable 
donor. At present, only a small fraction of pa-
tients who might be candidates for liver trans-
plantation can actually be treated, since there 
are no means of providing therapy analogous 
to that utilizing the artificial kidney to tide 
over prospective recipients while an organ is 
being found. Until an artificial liver is de-
veloped which will provide some of the more 
crucial hepatic functions, liver transplanta. 
tion will not be able to achieve anything like 
its true potential. 
OPERATIVE PROCEDURES 
et ai. 6 Such an approach to resuscitation- prior ~ 
to transplantation has not yet been tried. One 
reason is that the resuscitation obtained by 
this method has been of borderline 'benefit 
when weighed against the potential complica-
tions. In addition, even patients near death 
from hepatic disease can be brought through 
the transplantation procedure with almost im-
mediate improvement, providing the homo-
graft functions properly and promptly. 
DONOR HEPATECTOMY 
In removing a liver for eventual trans-
plantation, the essential steps are to incise the 
restraining ligaments that bind the organ to 
the diaphragm and body wall and to skele-
tonize the vessels and duct that must be 
anastomosed to the companion structures in 
the recipient. Figure 35-7 depicts the initial 
steps in this process. Then, the portal vein, 
hepatic artery, and common duct are dissected 
(Fig. 35-8). Details of the various surgical 
maneuvers are described elsewhere.19 The surprising ability of these moribund 
recipients. to survive such major surgery may 
be related partly to the troublesome operative 
bleeding which is almost invariablyencoun-
teredo The consequent necessity for major 
blood replacement frequently results in intra-
operative exchange transfusions of at least the 
magnitude reported by Trey et ai. to be of 
benefit in acute liver insufficiency.3o The co-
incidental therapeutic effect of massive trans-
fusion, as well as the immediate benefits of 
good hepatic function by the transplant, have 
usually resulted in patients returning to the 
THE RECIPIENT ORTHOTOPIC OPERATION 
Most of the steps in the recipient are iden-
tical or similar to those described above for 
the donor, except that long cuffs of vess.els 
and the duct are left with the patient rather 
than with the homograft. After removal of 
the liver, the residual anatomy consists of 
cuffs of four cut vessels, the common duct 
stump (except in biliary atresia), and the raw 
areas left by incision of the various hepatic 
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FIG. 35-7. Initial steps in hepatic homograft removal. A) The falciform and triangular 
lig:lments are incised as far away from the liver as possible so that they can be resutured 
later to the companion structures in the recipient. B) Exposure and initial dissection of the 
suprahepatic vena cava and its tributaries. This is done by entering the raw area formed by 
divergence of the leaves of the falcifonn and triangular ligaments. A short segment of the 
left hepatic vein (L.H.V.) is usually seen first. C) After incising the right triangular liga-
ment and the anterior leaf of the right coronary ligament , the liver is retracted to' the left , 
exposing the bare area of the right lobe. The right :ldrenal vein, usually the only posterior 
tributary of the retrohepatic vena cava , is ligated and divided. It is then possible to sweep 
behind the vena cava from the diaphragm to the renal. veins. If resistance is encountered, 
it usually indicates the presence of extra br:lnches which must be ligated and divided. 
R.a.v.-ligated right adrenal vein. D) Development of suprahepatic vena caval cuff. At this 
stage it is desirable to ligate :lnd divide one or more phrenic veins on each side. The latter 
step is not mandatory but it allows the mobilization of a longer segment for subsequent 
anastomosis . Each length C:ln also be obt:lined by dissecting off the diaphragmatic reflection, 
:lS is being shown. Inset. Cross-sectional appearance of the venous confluence above the liver 
as it is seen from above. The cloaca is fonned by the junction of the right and left hepatic 
veins with the inferior vena cava. (Starzl, T. E. and Putnam, C. W .I0) 
ligaments (Fig. 35-9). The reconstruction 
consists of anastomosing the individual vessels 
to the vessels of the homograft as quickly as 
feasible. The " standard" operation is shown 
in Fig. 35-10. 
The most commonly employed biliary re-
construction has been with cholecystoduo-
denostomy (Fig. 35-10) connecting the gall-
bladder to the duodenum with an external 
layer of interrupted silk and a continuous in-
1158 Transplantation of the Liver 
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. Gastroduodeno I '\ 
Stomach 
FIG. 35-8, Dissection of the 
portal triad, A) The common 
duct and the gastroduodenal 
and right gastric arteries are 
tied off and divided. Before 
ligation of the common duct, 
it should be determined that it 
communicates freely with the 
gallbladder via the cystic duct. 
If anomalies are present, fail-
ure to observe these precau-
tions may lead to accidental 
bile duct obstruction. B) The 
hepatic artery has been mo-
bilized far enough 50 that the 
anterior surf ace of the portal 
vein is uncovered. The coro-
nary vein entering the left side 
of the portal trunk is almost 
always found; this tributary is 
ligated and divided. C) The 
portal vein has been freed and 
the celiac axis mobilized , The 
splenic artery has not yet 
been ligated and divided . When 
the liver is removed, all the 
celiac axis is usually retained 
with the specimen and in chil-
dren, it may be advisable to 
include a segment of aorta as 
well. (Starzl , T. E. and Put-
nam , C. W.>O) 
Pancreas / 
/ 8. 
ternal layer of catgut. More will be said later 
about alternative techniques. . 
INTRAOPERATIVE COMPLICATIONS 
Anesthesia. Liver transplantation is an 
operation on the primary organ involved in 
the metabolism and detoxification of most 
common anesthetics. The challenge faced by 
the anesthesiologist is to administer correctly 
drugs that, first, are not hepatotoxic and sec-
ond, do not depend primarily on the liver for 
their degradation. In most of our first cases, 
reliance was placed mainly on combinations 
of volatile agents such as fluoroxene and 
nitrous oxide-oxygen mixtures in nonexplo-
sive concentrations, Such management, which 
was standardized by Aldrete,' penilitted use 
of the electrocautery, gave flexibility in light-
Proper hepatic a. 
ening or deepening anesthesia, and allowed 
anesthesia to be abruptly stopped if required 
by changing physiologic circumstances. More 
recently, the tendency has been to give anes-
thesia with less preoccupation about hepatic 
factors, but whether this" approach will be 
satisfactory remains to be seen. 
A number of swiftly changing metabolic 
conditions have to be carefully scrutinized 
during the anhepatic phase and immediately 
afterwards. Because the patient is at risk 
from acute hypoglycemia, a constant infusion 
of glucose is required. For proper control, 
frequent blood sugar determinations must be 
obtained. At the same time, the majority of 
recipients develop some element of acute 
metabolic acidosis, also requiring monitoring 
and correction. A third life-threatening com-
plication which is frequently seen just after 
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FIG. 35-9. The operative 
field after removal of the dis-
eased recipient liver. In the 
illustration, an incision in the 
diaphragm is shown as part 
of a thoracoabdominal expo-
sure. In all more recent cases, 
the chest has not been entered. 
C.d. = common duct; R.a. = 
hepatic artery; LV.C. = in-
ferior vena cava; P.v. = por-
tal vein. (Starzl, T. E., et al ti ) 
revascularization and lasts for several hours is 
hypokalemia. Apparently, the potassium is 
sequestered in the grafts to the extent that 
serum potassium concentrations may fall to as 
low as 1.5 mEq. per liter. 
Hemorrhage. Liver transplantation is a 
Icing, difficult and bloody procedure. Acute 
bleeding can be particularly trqublesome be-
cause of the mechanical factor of portal hyper-
tension present in nearly every patient. In 
addition, many of the normal coagulation fac-
tors that might help control hemorrhage are 
dependent on the liver and are therefore de-
fective to begin with in the diseased recipient. 
These coagulation deficiencies may become 
rapidly worse afterrevascularization of an 
organ which has suffered ischemic damage, 
apparently due to consumption of clotting fac-
tors by the injured graft. 8 
When hemorrhage occurs, all mechanical 
hemostatic tactics including ligature, suture, 
and cautery are used until the revascularized 
homograft can participate in what is hoped 
will be appropriate coagulation function. In 
our early patients, an attempt was made to 
treat such bleeding problems by administering 
thrombogenic agents such as epsilon amino 
caproic acid (EACA). However, for a number 
of years, we have studiously avoided such 
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FIG. 35-10. Recipient operation. In most recent 
cases cholecystoduodenostomy has been per-
formed for biliary drainage as shown. c.a. = ce-
liac axis; C.d. = common duct; G.B. = gallblad-
der; R.a. = hepatic artery; LV.C. = inferior 
vena cava; P .V. = portal vein; The kind of 
arterial anastomosis most commonly used. The 
homograft celiac axis or common hepatic artery 
is attached to the proper or common hepatic 
artery of the recipient. (Starzl, T. E., et al.: 
Orthotopic homotransplantation of the human 
liver. Ann. Surg., 168:392, 1968.) 
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practices since they seemed to cause an in-
creased incidence of thrombotic complications. 
Bile Duct Reconstruction. An end-to-end 
anastomosis of the common duct, if it were 
feasible (an option not available in recipients 
with biliary atresia), would have the ad-
vantage of preserving the sphincter of Oddi, 
thus reducing the chances of reflux of food or 
bacteria. Because of the factor of immunosup-
pression, this anastomosis carries a high risk 
of leakage and infection whether or not T-tube 
stents and drains are employed. Consequently, 
the safer if less elegant technique is usually 
used of anastomosing the gallbladder directly . 
to the duodenum and ligating the common 
duct (Fig. 35-10). 
If there are unrecognized anomalies such as 
a septum between the cystic and common 
ducts, ligation of the transplant common duct 
in conjunction with cholecystoduodenostomy 
may lead to disaster. In two cases in our ex-
perience, biliary drainage was inadvertentlJ 
obstructed when the common duct ligature 
closed both parallel passages (Fig. 35-11), a 
technical error that subsequent surgery failed 
to correct and that proved to~e fatal. 
Homograft 
common duct 
While cholecystoduodenostomy remains the 
preferred primary operation, the slightest 
suspicion that it will not provide effective 
drainage for anatomic or other reasons should 
lead to a decision for choledochocholedochos-
tomy or choledochoduodenostomy. With either 
procedure, the gallbladder should be removed. 
Vascular. Multiple arteries of either the 
graft or host have been' encountered in more 
than one-third of our cases, necessitating 
multiple anastomoses or other variant pro-
cedures which have had an increased risk of 
thrombosis.lv 
Other Complications. A homograft of 
exactly the right size may be difficult to find 
for any given recipient. Consequently, major 
size disparities often have had to be accepted. 
There have been few difficulties in using un-
dersized organs. For example, it has been 
possible to carry out orthotopic transplanta-
tion of a five-year-old liver to a full-sized 
adult. 
On the other hand, serious risks are borne 
when the donor organ is disproportionately 
large. Size disparities in this direction may 
lead to compression of the blood supply (Fig. 
FIG. 35-11. The anatomical basis for a technical error which cost the lives of two patients. 
Distal ligation of the double-barreled extrahepatic duct system resulted in total biliary 
obstruction. Despite surgical correction of the obstruction by choledochocholedochostomy, 
both patients died of septic complications. (Starzl, T. E. and Putnam, C. W.19) 
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FIG. 35-12. Anomalous hepatic arterial supply 
encountered in a pediatric recipient of an ortho-
topic homograft. The larger right hepatic arte!)! 
originated from the superior mesenteric artery; 
the small left branch came from the celiac axis. 
For this reason, the homograft celiac axis was 
anastomosed directly to the recipient aorta. Note 
the compression of the homograft arterial supply 
by the oversized homograft. This was not de-
tected and resulted in death 15 hours later. 
(Starzl, T. E., et a1.: Transplantation of the Liver. 
In Progress i1ll Liver Disease (Popper, H. and 
Schaffner, F., Eds.). New York, Crune and Strat-
ton, Inc., 1969.) 
35-12). This kind of complication tends to 
occur just as the abdomen is being closed, in 
which case an adverse chain of events leading 
to death may be set in motion, but not appre-
ciated until it is too late for correction. 
FIG. 35-13. Probable mech-
anism of operative injury of 
the right phrenic nerve in four 
pediatric patients. Note the Diaphragm 
inclusion of the nerve in the 
bite of the vascular clamp, 
which has been placed across 
the suprahepatic vena cava and 
which has also included a piece 
A long list of other technical pitfalls in-
cludes venous infarction of the right adrenal 
gland secondary to the sacrifice of the adrenal 
vein during removal of the diseased native 
liver, air embolism during this time, and crush-
ing of the right phrenic nerve by clamps 
placed too superiorly on the upper vena caval 
cuff (Fig. 35-13), to mention only three ex-
amples. A detailed discussion of these and 
other surgical problems has been ptlblished.1o 
NONIMMUNOLOGIC POSTOPERATIVE 
COMPLICATIONS 
DELAYED BILIARY OBSTRUCTION 
For reasons already described, the most 
comroonly used method of biliary duct recon-
struction has been with cholecystoduodenos-
tomy. In more than a half-dozen patients who 
had satisfactory initial bile drainage with this 
reconstruction, delayed obstructive jaundice 
appeared which was diagnosed by the tech-
nique of cholangiography iHustrated in Figure 
35-14 or. by transhepatic cholangiography 
(Fig. 35-15). The point of obstruction was at 
or near the juncfon of the cystic and common 
ducts. The first four patients with this com-
plication died in spite of the fact that two of 
them had secondary conversion of the cho-
lecystoduodenostomy to choledochoduodenos-
tomy. 
The pathological findings in the gallbladder 
and biliary ducts of these homografts were of 
great interest.13 The walls were infested with 
cytomegalovirus (CMV) which had caused 
swelling and shedding of the epithelial cells. 
Phrenic 
of diaphragm. (Starzl, T. E. 
and Putnam, C. W.10) Liver 
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FIG. 35-14. Cholangiography of hepatic homografts. A) (Left) Technique of dye injection through \ 
a duodenotomy and the anastomosis. B) (Right) Obstructed duct system in a liver recipient whose ' 
primary biliary reconstruction was with cholecystoduodenostomi (Martineau, G., et al. la ) 
Consequently, the etiology of this complica-
tion was at least partly inf~tious and pre-
sumably secondary to the immunosuppression 
required in all such cases. 
Recently, secondary reconstruction has been 
successfully carried out for the first time in 
several patients who had the syndrome _of 
cystic duct obstructidn. When the diagnosis 
was suspected, transhepatic cholangiography 
was undertaken which permitted high-quality 
definition of the problem (Fig. 35-15). With 
this information, re-exploration was carried 
out, the cholecystoduodenostomy (Fig. 35-
16A) was taken down, and the gallbladder 
removed. Then the dilated common duct was 
anastomosed to the hole in the duodenum 
which was the site of the previous anastomosis 
to the gallbladder (Fig. 35-16B). In most in-
stances,the . anastomosis was stented with a 
tube brought transhepatically through a stab 
wound (Fig. 35-16C) by the technique de-
scribed by Smi thY 
In these last cases, the secondary duct re-
construction was surprisingly well-tolerated, 
if this was done late after the first operation. 
The same thing was previously noted con-
cerning secondary ureteral repair in kidney 
transplantation recipients. In the latter pa-
tients, ureteral reconstruction six weeks or 
later after renal homotransplantation proved 
quite safe, whereas reintervention before this 
time carried a forbidding mortality.22 
Whether early or late after liver transplan-
tation, the best hope of rectifying a biliary 
obstruction and potential cholangitis is 
prompt recognition of the problem with pre-
cise diagnostic techniques of which transhe-
patic cholangiography is without doubt the 
most important. Because of the background 
of immunosuppression, unrecognized cho-
langitis secondary to mechanical duct obstruc-
tion has extremely serious implications in liver 
recipients. In both experimental animals and 
man, homograft cholangitis may lead to mul-
tiple intrahepatic abscesses which cannot be 
effectively treated if permitted to exist for too 
long. Bacteremia results, usually with micro-
organisms that are indigenous to the intestinal 
tract (Fig. 35-17). All of the manifestations 
of gram-negative septicemia, including cardio-
vascular collapse, may follow. 
In following patients with liver transplanta-
tion through the early postoperative period, 
blood cultures are frequently obtained. If 
these become positive, biliary duct obstruction 
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FIG. 35-15. Transhepatic cholangiogram of a liver recipient whose primary biliary recons truc-
tion was with cholecystoduodenostomy. After the cholangiogram revealed obstruction at the level of 
the cysti c duct , a choledochoduodenostomy was performed with relief of the obstruction, 
or some other complication relating to the 
homograft itself, such as devascularization, 
should be suspected and very decisive diagnos-
tic steps should then be taken. 
OTHER GASTROINTESTINAL PROBLEMS 
Gastrointestinal hemorrhage is a rather com-
mon complication of the steroid component 
of the immunosuppressive regimen that all 
such organ recipients require . This has been 
particularly well-documented in the renal 
transplant population,16 but the same thing 
has been reported in liver recipients .1o The 
most common etiology of the hemorrhage is 
peptic disease of the duodenum or stomach, 
but fatal gastrointestinal bleeding has resulted 
from enteritis caused by Candida albicans in-
festation of the bowel wall. 
The same kind of fungal infection has also 
been responsible for at least one example of 
post-transplantation pancreatitis. In addition, 
a number of liver recipients dying from a few 
days to more than a year after transplantation 
have had histopathologic findings of idiopathic 
acute, subacute or chronic pancreatitisY Pan-
.creatitis is undoubtedly related at least in part 
to the need for chronic immunosuppressionKl~ 
1164 Transplantation of the Liver 
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AN INTERESTIN'G CARDIOCIRCULATORY 
COMPLICATION 
After liver transplantation in children, ar-
terial hypertension has been observed quite 
frequently. This has been attributed partly to 
the effects of steroid therapy but, in addition, 
the inability of the new liver to deal with 
pressor substrates may have been contribu-
tory. For example, evidence has been reported 
in pediatric liver recipients of defective 
tyramine degradation.19 Tyramine is an aro-
matic amine which is normally formed in the 
gastrointestinal tract by the decarboxylation 
of tyrosine which is then detoxified by hepatic 
monoamine oxidase. The sympathomimetic 
properties of tyramine are thought to be by 
its induction of norepinephrine release from 
adrenergic nerve endings. With defective early 
postoperative hepatic function, the tyramine 
and possibly other substances have apparently 
accumulated to physiologically significant 
levels. 
B. 
FIG. 35-16. Technique for 
conversion of cholecystoduo-
den ostomy to choledochoduo-
.denostomy. A) After transhe-
patic or operative cholangiog-
raphy has demonstrated ob-
struction, the cholecystoduo-
denostomy is taken down and 
the gallbladder removed. B) 
The dilated common duct is 
then anastomosed to the hole 
in the duodenum at the site of 
the previous cholecystoduode-
nostomy. C) The anastomosis 
is stented with a tube brought 
out transhepatically and 
through the abdominal wall. 
IMMUNOSUPPRESSION 
With the transplantation of any whole or-
gan from other than an identical twin donor, 
the prevention of rejection is the unique prob-
lem which distinguishes this kind of surgery 
from all others. Control of rejection depends 
upon the systematic weakening of the host 
defenses which ordinarily provide resistance 
against invasion by a wide spectrum of micro-
organisms. 
TECHNIQUES OF IMMUNOSUPPRESSION 
The therapeutic regimens used for hepatic 
. recipients were evolved and tested in patients 
treated by renal homotransplantation. These 
treatment programs have been used with very 
little modification in liver recipients. 
Double Drug Therapy. The first protocol 
which was used for organ recipients in most 
transplantation centers throughout the world 
consisted of "double drug" treatment with 
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azathioprine and the synthetic adrenal corti-
costeroid, prednisone. 10, 14, 25, 32 Evolution of 
the use of these two agents together, appre-
ciation of their marked synergism, and dem-
onstration that rejection could be easily re-
versed by increasing the steroid doses were 
among the advances which made clinical 
transplantation practical and which intro-
duced what is known as "the modern era" of 
this clinical field.18 But, in spite of fair results 
with renal transplantation, double drug ther-
apy either did not prevent rejection of hepatic 
homografts in the early trials or else it proved 
too toxic to permit host survival. All patients 
treated with liver transplantation from 1963 
to 1966 under this kind of treatment died 
within a month or less.19 
Triple Drug Therapy Including ALG. 
In 1966, heterologous antilymphocyte globu-
lin (ALG) was introduced clinically at our 
center as a third immunosuppressive agent 
added to the drugs mentioned above.21 Start-
ing then and continuing un til early 1971, this 
"triple drug" therapy was given to essentially 
all of our renal, hepatic and cardiac recipi-
ents. ALG is the globulin removed from the 
serum of an animal immunized against 
lymphoid tissue obtained from the species to 
be treated. Our greatest experience has been 
with ALG obtained from horses immunized 
against human lymphocytes (FIg. 35-18). It 
has seemed to us that rejection has been more 
easily and regularly controlled and the risks 
and morbidity imposed by 'the necessity for 
high-dose steroid therapy have been reduced 
with the use of the triple drug program. 
More recently, cyclophosphamide, a well-
known cancer chemotherapeutic agent with 
potent cytotoxic properties, has been used 
during the early postoperative period instead 
of azathioprine in the triple drug regimen 
(Fig. 3 5-19). There are potential advantages 
to the use of cyclophosphamide, including the 
fact that it apparently has somewhat less 
hepatotoxicity than azathioprine. In addition, 
it may retain its potency better than azathio-
prine under conditions of abnormal liver 
function. 
MANIFESTATIONS OF REJECTION 
In spite of immunosuppressive therapy, 
most liver recipients develop some signs of 
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FIG. 35-17. An explanation of the predisposi-
tion of the liver to bacterial sepsis. Presumably 
the invading micro-organisms enter via the portal 
vein or through the reconstructed biliary tract. 
(Starzl, T. E., et al.: Orthotopic homotransplanta-
tion of the human liver. Ann Surg. 168:392, 
1968.) 
hepatic homograft rejection; usually these ap-
pear within the first few postoperative weeks. 
Jaundice occurs with increases in both the 
total and conjugated bilirubin, as might be 
expected with biliary duct obstruction. How-
ever, it has come to be recognized that these 
biochemical manifestations are a reflection of 
intrahepatic cholestasis. Consequently, it is 
not surprising that sharp rises in the alkaline 
phosphatase also occur. The fact that both 
rejection and biliary obstruction may lead to 
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TRANSPLANTATION 
OT 19 4 Y.O. (j 
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FIG. 35-18. A 4-year-old child with intrahepatic biliary atresia who was treated with orthotopic 
liver transplantation. A ve~D transient rejection occurred after one month. This underwent almost 
immediate and complete remission. A late rejection which began on postoperative day 72 was also 
easily controlled. Note the change in time scale after four months. The child survived 3% years 
post-transplantation, nearly all of that time in good health.28 The normal enzyme values in inter-
national units at this age are: alkaHne phosphatase, 57 to 151; SGOT 3 to 27; and SGPT, 2 to 30. 
(Starzl, T. E. and Putnam, C. W.lD) 
the same pattern of obstructive jaundice may 
make the differential diagnosis impossible 
without cholangiography, as described·earlier. 
With rejection, additional abnormalities in 
the liver function tests may indicate variable 
hepatic necrosis. There are increases in the 
SGOT, SGPT, and the liver specific enzyme, 
isocitric dehydrogenase. The synthetic func-
tions of the liver are surprisingly well-main-
tained even with advanced degrees of rejec-
tion. _ 
The inanifestations of rejection occupy a 
wide spectrum. The process may be very in-
dolent with obstructive jaundice being the 
main finding (Fig. 35-20), or it can even be 
so mild that clinically obvious icterus never 
appears. At the other extreme, rejection may 
occur as an acute crisis (Fig. 35-21) with evi-
dence of massive tissue necrosis. Then, bac-
teremia can complicate matters, apparently as 
the result of seeding by bacteria from the in-
testinal tract of necrotic foci within the liver. 
Fortunately, rejection is a highly reversible 
process with increased doses of steroids, or 
sometimes without any adjustment in therapy 
at all (Figs. 35-18 & 35-21). After rejection 
is controlled, it is often possible to ultimately 
'reduce the amount of day-to-day immunosup-
pression required to prevent a recurrence. 
PENALTIES OF IMMUNOSUPPRESSION 
Risks with All Organs. Heightened sus-
ceptibility to infection is the most obvious 
penalty of a depressed immune system. In the 
early compilations of results in kidney trans-
plant recipients, a repeated and often fatal 
chain of events was infection by bacteria, 
fungi, viruses, or even protozoa. When these 
infections were caused by pathogenic bacteria 
against which effective antibiotics were avail-
able, treatment was usually not difficult. How-
ever, infection with opportunistic fungi or 
other microorganisms for which antibiotics 
are not available emerged as the most serious 
late problem after transplantation. 
It has also become obvious 26 that chroni-
cally immunosuppressed patients have an in-
creased vulnerability to de novo malignancies. 
In our own series of chronic survivors after 
renal transplantation, more than 5 per cent 
have developed either mesenchymal or epi-
thelial malignant tumors. Almost all other ma-
jor transplantation centers have recorded the 
same complication which, as discussed earlier 
in this chapter, is presumably due to failure 
of the depressed immunologic surveillance 
mechanism to identify mutant neoplastic cells 
as alien and to eliminate them or to restrict 
their growth. Fortunately, these tumors can 
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usually be treated by conventional means, in-
cluding surgical excision and radiotherapy. 
To date, there has only been one example of 
de novo malignancy in a chronically surviving 
recipient of a hepatic homograft. This was in 
a patient treated by CaIne and Williams in 
England. Some months after opK~rationI a 
reticulum cell sarcoma developed which in-
volved the new liver and which was a major 
factor in causing death. 
Extra Risks for Liver Recipients. In addi-
tion to the foregoing general liabilities of im-
munosuppression, there are some special risks 
for the liver recipient. Of the chronic surviv-
ors after hepatic transplantation in our center, 
about one-third have developed some serologic 
evidence of serum hepatitis by tests for Aus-
tralia antigen (Fig. 35-19). In other liver 
WEIGHT 50- 47 Kg. 
15 YEAR OLD d' 
~~~~dlq 150 (I U) 
100 
50 
....., .......... --~--o 
120 I!SO 180 
TIME IN DAYS 
FIG. 35-19. The course of a patient who had triple drug therapy with cyclo-
phosphamide (instead of azathioprine), prednisone and horse ALG. Note that 
there was excellent liver function except during the second and third post-
operative months, when the patient developed jaundice and rises in the levels 
of the serum transaminases. These abnormalities were coincidental with the 
appearance of Australia antigen in the serum and consequently were probably 
reflections of serum hepatitis rather than rejection. The recipient's original 
diagnosis was Wilson's disease. He is well 2% years after transplantation. 
(Starzl, T. E. and Putnam, C. W. In Abdominal Operations (Maingot, R., Ed.), 
6th Edition. New York, Appleton-Century-Crofts, 1974, pp. 1247-1271.) 
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FIG, 35-20. The course of a patient after two orthotopic liver transplantations. The second liver 
replacement was 380 days after the first. At the time of retransplantation, local recurrence of the 
neoplasm was demonstrated, but there was very little tumor in the liver to account for its func-
tional deterioration, qhrougho~K the period of follow-up very small doses of azathioprine were given, 
usually 12.5 mg, per day. Shortly after the discontinuance of the first course of ALG, a chronic 
rejection developed. An effort at desensitization to the horse globulin was not successful. Despite 
the deepening jaundice, the synthetic functions of the liver were well-maintained for a long time. 
Note the low gamma globulins late in the course. The liver function tests "were performed with 
microchemical techniques. With these methods, the normal ranges in International Units (I.U.) of 
alkaline phosphatase, SGOT and SGPT, respei;tively,ftfc 60 to 260,0 to 65, and 0 to 55. (Starzl, T. E. 
and Putnam, c.. W.19) 
recipients, hepatotoxicity of the immunosup-
pressive drugs rather than uncontrolled rejec-
tion may have been responsible for deteriora-
tion of graft function, although this possibil-
ity has been difficult to prove. With liver 
malfunction, whatever its cause, dose control 
of some of the immunosuppressive agents may 
become difficult since the liver participates in 
their pathways of activation and/or degrada-
tion. 
Postoperative sepsis of the graft itself has 
proven to be a special problem, as alluded to 
earlier, no doubt partly because of the ana-
tomic location of the orthotopically placed 
organ, interposed between the intestinal tract 
and the heart. Bacteria from the bowel, par-
ticularly of the gram-negative variety, can 
thus be brought into contact with the trans-
planted liver via the intestinal veins draining 
into the portal vein or alternatively by retro-
grade spread up the duct system after passage 
through the biliary anastomosis. In either 
event, the presence of nonviable or obstructed 
hepatic tissue provides a perfect medium for 
bacteriologic growth and then systemic dis-
semination (Fig. 35--17). 
CLINICAL RESULTS 
Our own experience, including all patients 
treated with orthotopiC liver transplantation, 
has consisted of 56 cases. Survival of at least 
one year was obtained in 16 (29<,1'0) of the 
56 recipients. 
The life survival curve of these patients 
(Fig. 35-22) has a familiar appearance to 
students of renal transplantation except that 
the immediate mortality was so much higher 
than with kidneys. The vast majority of the 
deaths occurred before the end of the second 
month. Technical problems of one kind or 
another made a major contribution to this 
mortality. By six months, the attrition was 
stabilized at a low rate which would have 
been even more impressive except that three 
deaths occurred in the twelfth to fifteenth 
months from recurrences of the hepatomas for 
which the transplantations had been per-
formed in the first place. This subject was 
covered earlier in the chapter. 
After one year, 8 of 16 twelve-month sur-
vivors were lost for the reasons and at the 
times shown in Table 35-5. The causes of 
late failure included the three examples of 
carcinomatosis just all1lded to, late chronic 
homograft rejection (three examples) and se-
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rum hepatitis (two examples). Deaths have 
occurred as long as 3 Y2 years after opera-
tion.28 The eight patients still living have 
been followed for 48, 42, 28, 24, 17, 16, 15 
and 14 months post-transplantation. 
So far, with one possible exception, no dis-
ease has been identified with a highly favor-
able prognosis after transplantatiQn (Table 
35-6). The possible exception is Wilson's dis-
ease. This disorder is an inborn error of 
metabolism characterized by the progressive 
accumulation of copper in tissues with subse-
quent degenerative changes that affect the 
brain and liver among other organs. Discolor-
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FIG. 35-21. The course of a patient who died of recurrent hepatoma despite total hepatectomy and 
orthotopic liver transplantation. He passed through an early and vigorous rejection crisis, but then 
had normal liver function for many months. The recurrent tumor was first diagnosed with the liver 
scan about eight months after transplantation, and biopsy confirmation was obtained more than a 
month later. The episodic septicemia and deterioration of liver function were probably the conse-
quences of invasion by tumor of the extrahepatic ducts. The intermittent large steroid doses were 
given on the chance that rejection was also occurring. From left to right, the different shadings in 
the ALG bar indicate that the injections were daily, every other day, every three days and twice a 
week. The normal alkaline phosphatase range in Bessey-Lowry units is 1 to 3. For the SGOT and 
SGPT, the normal ranges are 60 to 100 and 5 to 35 units, respectively. SH Antigen represents posi-
tive tests for Australia antigen. (Starzl, T. E., and Putnam, C. W.IO) 
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FIG. 35-22. Life survival 
curve for 56 recipients of or-
thotopic hepatic homografts. A 
minimum follow-up of 15 
months is available for each 
case. Note that the majority of 
'" deaths occurred in the first two 
months post-transplantation, 
after which the curve achieves 
a much more gentle slope. The 
asterisks indicate late death o+-~--~-r--r--r~r-I--K--K-~--r--r--r--r-K 
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ation of the cornea by copper is seen as the 
Kayser-Fleischer ring with slit lamp examina-
tion. Abnormal biochemica~Ifindings may in-
clude elevated albumin-bo~d serum copper, 
increased urinary excretion of copper, low 
levels of the copper-coIltaining serum protein 
ceruloplasmin ana low total serum copper. 
The nature of the primary metabolic defect 
remains obscure (see also Chapter 30).-
At our institution, two boys with Wilson's 
disease had liver replacement 4 and 2Ya 
TABLE 35-5. 16 ONE-YEAR SURVIVORS AFTER 
ORTHOTOPIC LIVER TRANSPLANTATION 
ALIVE 
DIED 
8/16 
8/16 
Ilk TO 4 YEARS 
1 TO 3Y:l YEARS 
12 months-Cancer '" 
12 months-Serum hepatitis, liver failure 
14 months:-:-Cancer 
15 months-Cancer 
15 months-Rejection, liver failure 
20 months-Chronic aggressive hepatitis and dis-
seminated Nocardia infection t 
30 months-Rejection, liver failure 
42 months-? Rejection, liver failure 
... This patient actually died a few days short of 
one year. 
t The homograft showed severe chronic aggressive 
hepatitis, just as in her previously removed native 
liver. 
the 4 patients lost after 6 
months died of carcinomatosis. 
TABLE 35-6. INDICATIONS FOR AND RESULTS 
OF ALL ORTHOTOPIC LIVER TRANSPLANTA-
TIONS AT THE UNIVERSITY OF COLORADO TO 
JULY, 1973 
No. ALIVE ALIVE 
PATIENTS 1 YR, Now 
Biliary atresia 27 7 3 
-Hepatic malignancy 13 3 0 
Chronic aggressive 
hepatitis 
Au negative 7 2 2 
Au· positive 1 1 0 
Laennec's cirrhosis 4 0 0 
Wilson's disease 2 2 2 
] uvenile hepatitis . 1 0 0 
Congenital biliary 
cirrhosis 1 
Total 56 16 8 
years ago for terminal hepatic failure and 
moderate cirrhosis plus severe neurologic in-
volvement, respectively. Both patients had a 
high liver copper value. The second boy had 
l'ow ceruloplasm and total serum copper and 
increased urinary copper excretion. In this 
second case, the patient apparently went 
through a bout of serum hepatitis associated 
with Australia antigenemia early in the post-
operative course (Fig. 35-19) and from which 
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there was complete recovery. The 100 per cent 
good results in these two cases is probably 
only a coincidence, but the observations, in-
cluding analyses from liver biopsies, have sug-
gested that liver replacement is a curative 
procedure for Wilson's disease. As a corollary, 
the findings are consistent with, although they 
do not absolutely prove, the statement that 
the metabolic perturbation of Wilson's disease 
is liver-based, as recently reviewed by Groth 
et al.9 
The single largest, group of recipients in 
our series (27 in all) has comprised extra-
hepatic (24 examples) or intrahepatic (3 ex-
amples) biliary atresia. The one-year survival 
was a disappointing 26 per cent (7 of 27). 
The second largest category of recipients 
in our experience was primary hepatic malig-
nancy, containing 13 patients. Because these 
recipients did not have such severe portal 
hypertension, the procedures were technically 
less difficult, less time-consuming and less 
bloody. Unfortunately, this advantage was 
more than outweighed by the high incidence 
of recurrent tumor (see above) which ac-
counted for a half-dozen deaths, before or 
after the first year. 
The other miscellaneous contributions to 
the case material are listed in Table 35-6. So 
far, we have had no long-term survivors 
among patients with alcoholic cirrhosis. Three 
patients with chronic aggressive hepatitis 
have lived for a long time, including one 
whose serum contained Australia antigen. 
This last recipient had liver transplantation 
in the summer of 1970. The Australia antigen 
became negative by all tests except radio-
immunoassay (RIA) for almost two months, 
although trace quantities could still be de-
tected by RIA. After about two months, all 
tests returned to positive at the same time as 
a clinically obvious bout of acute serum hepa-
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titis appeared. She recovered from this, but 
her Australia antigen remained positive until 
she died of recurrent chronic aggressive hepa-
titis 20 months later. Nevertheless, her health 
was satisfactory for all but the last month or 
so of her survival. Even though her original 
disease obviously affected the ultimate out-
come, we will probably do moiD~ such cases 
in the future in view of the fact that the pa-
tient had substantial prolongation of mean-
ingful life. 
CAUSES OF PAST FAILURES 
The operation of liver transplantation is an 
extraordinarily difficult undertaking, exceed-
ing in complexity any other ever undertaken 
by the authors. Furthermore, the procedure 
must usually be done on patients who, under 
'any other conceivable circumstance, would 
categorically be considered inoperable. Under 
these conditions, it is not surprising that tech-
nical complications have' been responsible for 
much of the exceedingly heavy mortality of 
the first two Ok three months (Fig. 35-22). 
Even if thlf operation has been a perfect 
one, the depleted state of the patient may 
make it difficult to be out of bed and active 
during the critical early phase of convales-
cence. The consequences may be disastrous, 
particularly since immunosuppression is re-
quired at the highest doses in the first few 
weeks or months in order to prevent rejection. 
For those patients who succeed in running 
the fearful gauntlet of the first half-year, the 
chances become bright of living on for pro-
longed periods if the original diagnosis was 
not cancer. As a consequence, there are now 
several patients alive in the third, fourth and 
fifth years after hepatic transplantation who 
are living proof that the feasibility stage of 
liver transplantation has been passed. 
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